Clorox posts 33% sales growth and EPS beat in Q1 FY2027
The Clorox Company reported first‑quarter fiscal 2027 results on Nov. 2, 2026. Net sales rose 33% to $1.91 billion, driven by the GOJO acquisition and 18% organic growth. Diluted EPS jumped 114% to $1.39 and adjusted EPS reached $1.55, both beating estimates. Gross margin slipped to 40.4% and the company lowered its gross‑margin outlook to 41.5% because of higher input costs, while reaffirming full‑year EPS guidance of $5.70‑$6.00 per share.
Why it matters
The earnings beat and raised guidance may support the stock, as noted by analysts who highlighted the strong top‑line growth. The lower margin outlook signals continued cost pressure that could affect future profitability.
Key facts
- 1Net sales increased 33% to $1.91 billion. prnewswire.com
- 2Organic sales grew 18% year over year. prnewswire.com
- 3The GOJO acquisition contributed about 15 points to sales growth. prnewswire.com
- 4Diluted EPS rose 114% to $1.39. prnewswire.com
- 5Adjusted EPS was $1.55, beating estimates by $0.48. seekingalpha.com
- 6Gross margin fell to 40.4% from 41.7%. prnewswire.com
Summary written by AlphAI AI Desk from 9 of 9 sources. Not investment advice. Figures are as stated by the linked sources.